Background: The role of machine perfusion after kidney transplantation (KT) in extended criteria donors (ECD) is unclear, and the current evidence in the literature remains controversial. Methods: We present an open-label single center randomized trial where 109 patients undergoing KT with ECD grafts between January 2019 and December 2022 were randomized to receive kidneys treated with either hypothermic oxygenated perfusion (HOPE, n = 54) or static cold storage (SCS, n = 55) alone. The primary endpoint was the incidence of delayed graft function (DGF). The secondary endpoints included postoperative complications and graft function and survival in the first year after KT. Results: The trial failed to meet its primary endpoint. DGF developed in 31 (57%) and 37 (67%) patients in the HOPE and SCS groups, respectively (p = 0.3). Posthoc analysis showed that HOPE was associated with a lower risk for DGF for grafts from donors aged 60 years or older (OR 0.32, 95% CI 0.12–0.87, p = 0.026) and in patients undergoing dual KTs (OR 0.22, 95% CI 0.06–0.87, p = 0.031). Conclusions: HOPE does not reduce the rate of DGF after KT in ECD donors. However, HOPE appears to be associated with better outcomes in the case of older donors and dual KTs.

Dajti, G., Vaccaro, M.C., Germinario, G., Comai, G., Caputo, F., Odaldi, F., et al. (2025). Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial. CLINICAL TRANSPLANTATION, 39(5), 1-7 [10.1111/ctr.70166].

Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial

Dajti, Gerti;Vaccaro, Maria Chiara;Germinario, Giuliana;Comai, Giorgia;Caputo, Francesca;Odaldi, Federica;Maroni, Lorenzo;Cuna, Vania;Zanfi, Chiara;Prosperi, Enrico;Bonatti, Chiara;Fallani, Guido;Radi, Giorgia;Stocco, Alberto;Provenzano, Michele;Capelli, Irene;Del Gaudio, Massimo;La Manna, Gaetano;Ravaioli, Matteo
2025

Abstract

Background: The role of machine perfusion after kidney transplantation (KT) in extended criteria donors (ECD) is unclear, and the current evidence in the literature remains controversial. Methods: We present an open-label single center randomized trial where 109 patients undergoing KT with ECD grafts between January 2019 and December 2022 were randomized to receive kidneys treated with either hypothermic oxygenated perfusion (HOPE, n = 54) or static cold storage (SCS, n = 55) alone. The primary endpoint was the incidence of delayed graft function (DGF). The secondary endpoints included postoperative complications and graft function and survival in the first year after KT. Results: The trial failed to meet its primary endpoint. DGF developed in 31 (57%) and 37 (67%) patients in the HOPE and SCS groups, respectively (p = 0.3). Posthoc analysis showed that HOPE was associated with a lower risk for DGF for grafts from donors aged 60 years or older (OR 0.32, 95% CI 0.12–0.87, p = 0.026) and in patients undergoing dual KTs (OR 0.22, 95% CI 0.06–0.87, p = 0.031). Conclusions: HOPE does not reduce the rate of DGF after KT in ECD donors. However, HOPE appears to be associated with better outcomes in the case of older donors and dual KTs.
2025
Dajti, G., Vaccaro, M.C., Germinario, G., Comai, G., Caputo, F., Odaldi, F., et al. (2025). Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial. CLINICAL TRANSPLANTATION, 39(5), 1-7 [10.1111/ctr.70166].
Dajti, Gerti; Vaccaro, Maria Chiara; Germinario, Giuliana; Comai, Giorgia; Caputo, Francesca; Odaldi, Federica; Maritati, Federica; Maroni, Lorenzo; C...espandi
File in questo prodotto:
File Dimensione Formato  
Clinical Transplantation - 2025 - Dajti - Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 294.38 kB
Formato Adobe PDF
294.38 kB Adobe PDF Visualizza/Apri
ctr70166-sup-0001-suppmat.pdf

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 187.13 kB
Formato Adobe PDF
187.13 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1015636
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact